University of Pavia at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

University of Pavia brings 2 presentations to ESGCT 2026 in Hamburg. Its work covers nucleic acid delivery to the heart and how cells themselves react to AAV. One project uses inhaled nanoparticles to carry allele-specific small RNAs to heart muscle in a model of an inherited arrhythmia.

OrganizationESGCT 2026 Attendance
Universities & institutes
Public university in Pavia, Italy.
Poster
Wed Oct 28
1:30pm–3:30pm
Inhalable nanoparticles mediate cardiotropic delivery of allele specific siRNAs in a mouse model ofCatecholaminergic Polymorphic Ventricular Tachycardia
Cardiovascular & Muscular diseases
Talk
Thu Oct 29
8:30am–10:30am
Insight into cell-autonomous immune responses to AAV transduction
SESSION 7a: Immune responses to GT
Vectors and delivery (AAV, lentiviral, LNP)

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from University of Pavia

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction